BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Sankyo Pharma Inc. 

Two Hilton Court

Parsippany  New Jersey  07054  U.S.A.
Phone: 973-359-2600 Fax: 973-359-2645


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals

Collaborations

Forest Laboratories, Inc.  Developer and Forest's partner in the promotion of Benicar, an angiotensin II receptor blocker (ARB) for the treatment of hypertension.





 Company News
Sankyo Pharma Inc. Release: U.S. Subsidiaries Join Together To Form Daiichi Sankyo, Inc. 4/3/2006 11:03:22 AM    More...
Sankyo Pharma Inc. Release: First Data To Show Addition Of A Bile Acid Sequestrant (WelChol, colesevelam HCl) To Statin Therapy Significantly Reduces Median Hs-CRP Levels 11/15/2005 11:30:36 AM    More...
Sankyo Pharma Inc. Halts Development Of Pactimibe (CS-505) 10/26/2005 12:06:24 PM    More...
Sankyo Pharma Inc. Release: New Study Finds Additional LDL-C Drops When WelChol(R) (colesevelam HCl) Is Added To Fenofibrate In Patients With Mixed Hyperlipidemia 10/19/2005 5:13:18 PM    More...
Daiichi Pharmaceutical (JPN), Sankyo Company, Ltd. (SKXOF.PK) Sign Basic Agreement To Integrate Businesses 10/19/2005 5:12:51 PM    More...
Sankyo Pharma Inc. Release: New Study Demonstrates Co-Administration Of WelChol(R) (colesevelam HCI) And TriCor(R) (fenofibrate tablets) Resulted In No Significant Drug-Drug Interactions 10/19/2005 5:11:50 PM    More...
Kirin Brewery Co., Ltd. (KNBWY) , Sankyo Company, Ltd. (SKXOF.PK) To Terminate Joint Marketing Of Renal Anemia Drug ESPO And Leukopenia Drug GRAN By Next March 10/19/2005 5:11:50 PM    More...
Sankyo Pharma Inc. Release: New Data Demonstrates That BENICAR And BENICAR HCT Achieve JNC 7 Blood Pressure Goals 10/19/2005 5:11:31 PM    More...
Dendrite International, Inc. (DRTE) Awarded Sales And Marketing Data Outsourcing Contract From Sankyo Pharma Inc. 10/19/2005 5:10:52 PM    More...
Forest Laboratories, Inc. (FRX) Announces That Neramexane Did Not Demonstrate Statistical Significance In Recently Completed Phase III Trial In Patients With Moderate To Severe Alzheimer's Disease 10/19/2005 5:10:29 PM    More...
12

//-->